Trials / Completed
CompletedNCT01114204
A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
A Phase III, Randomized, Open-label, Active-Controlled, Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 605 (actual)
- Sponsor
- AMAG Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the efficacy and safety of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferumoxytol | IV Ferumoxytol |
| DRUG | Iron Sucrose | IV Iron Sucrose |
Timeline
- Start date
- 2010-08-10
- Primary completion
- 2011-11-09
- Completion
- 2012-06-25
- First posted
- 2010-05-03
- Last updated
- 2022-04-21
- Results posted
- 2018-06-11
Locations
96 sites across 14 countries: Australia, France, Germany, Hungary, Italy, Latvia, Lithuania, Poland, Romania, South Africa, South Korea, Spain, Ukraine, United Kingdom
Source: ClinicalTrials.gov record NCT01114204. Inclusion in this directory is not an endorsement.